Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Therachon

Therachon
2014 FOUNDED
PRIVATE STATUS
M&A LATEST DEAL TYPE (Announced)
$810M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of novel therapeutics intended to facilitate treatment for rare genetic diseases. The company develops pipeline of therapeutics focused on rare gastrointestinal and musculoskeletal disorders and conditions, enabling medical practitioners to treat patients with short bowel syndrome and other severe conditions.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Aeschenvorstadt 36
  • 4051 Basel
  • Switzerland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Therachon’s full profile, request a free trial.

Therachon Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 08-May-2019 $810M 00000 00000 Announced Clinical Trials - Phase 1
4. Mezzanine 09-Aug-2018 0000 00000 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 05-Jan-2017 0000 0000 Completed Startup
2. Secondary Transaction - Private Completed Startup
1. Seed Round 01-Jan-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Therachon Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IFM Therapeutics Formerly VC-backed Boston, MA 0000 000000&0 0000
000000 0000 Formerly VC-backed Jerusalem, Israel 00 00000 00000000 00000
000000 00000000000 Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
00 000000000000 Venture Capital-Backed Guilford, CT 00 0000 00000000000 0000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Therachon Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 09-Oct-2018 000000000000000000 Biotechnology 0000 0000000000 00
To view this company’s complete investment and acquisition history, request access »

Therachon Subsidiaries (1)

Company Name Industry Location Founded
000000000 Biotechnology Montreal, Canada 0000
To view this company’s complete subsidiary history, request access »

Therachon Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cowen Group Investment Bank Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
Tekla Capital Management Investment Bank Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Therachon Executive Team (10)

Name Title Board
Seat
Contact
Info
Luca Santarelli MD Co-Founder, Chief Executive Officer & Board Member
Claudia D'Augusta Ph.D Chief Financial Officer
Richard Porter Ph.D Chief Operating Officer
Aled Williams Chief Commercial Officer and Head of Patient Access
Elvire Gouze Ph.D Scientific Co-Founder

1 Former Executive

You’re viewing 5 of 10 executives. Get the full list »

Therachon Board Members (10)

Name Representing Role Since Contact
Info
Chahra Louafi Bpifrance Board Member 000 0000
Hans Schikan Ph.D Self Board Member 000 0000
Jørgen Søberg Petersen Novo Holdings Board Member 000 0000
Luca Santarelli MD Therachon Co-Founder, Chief Executive Officer & Board Member 000 0000
Patrick Machado JD Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 10 board members. Get the full list »